Responsible in designing and conducting formulation development experiments leading todevelopment of patent non-infringing and/or bioequivalent products (Immediate-release,controlled-release and sustain-release oral dosage form).Evaluate process and formulation variables to develop robust formulation.Developed process for tablet manufacturing employing a variety of pharmaceuticalmanufacturing techniques, include high and low shear granulation, fluidized… Show more Responsible in designing and conducting formulation development experiments leading todevelopment of patent non-infringing and/or bioequivalent products (Immediate-release,controlled-release and sustain-release oral dosage form).Evaluate process and formulation variables to develop robust formulation.Developed process for tablet manufacturing employing a variety of pharmaceuticalmanufacturing techniques, include high and low shear granulation, fluidized bedgranulation.Experienced with numerous related pharmaceutical process, including blending, milling,compressing and coating.Prepared pivotal batches for bioequivalence studies and registration for several dosageform.Prepare and review BMR/MMR; Product Development Report (PDR), ProcessCharacterization/Validation Protocol and Reports, Quality Overall Summary (QOS) andother necessary documents to support NODCAR filing.Collaborate with Business Development, Project Management, Process Engineers,Manufacturing Operators, Quality Control, Microbiology, Validation, QA and Regulatorydepartment to coordinate Pilot, registration and commercial batch manufacturing.Provide vital input in Scale-up and technology transfer process in collaboration withManufacturing Plant and Production personnel.Holds responsibility of coming up with new techniques and procedures for finding outappropriate resolutions for the technical issues regarding formulation.Executed multiple R&D Projects in a fast paced generic environment. Productdevelopment, pre-formulation and formulation design.Successfully executed and supervised Pivotal, Pilot and NODCAR batches with reference tothe QbD and guidelines provided by the FDA.R&D Senior at Hikma Egypt Show less

R&D Senior AUGUST 2007-April 2009•Responsible for the development of generic pharmaceutical dosage forms.Evaluated formulations and proposed unique strategic approaches for development ofunique dosage forms.Worked in the lab utilizing the appropriate equipment and facilities to achieve target goal.